PRECISION-CPR: PRecision-Controlled Ventilation in CPR
Key facts
- Who runs it
- Rush University Medical Center
- Where
- Chicago, United StatesSee the siteAlso in 1 other country, 1 site
- Trial code
- Status
- Not yet recruiting
- People taking part
- 852 people, planned
- Started
- 1 Sept 2026
- Expected to end
- 31 Dec 2030
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Precision-Controlled Ventilation with Real-Time Feedback
- Standard Manual Ventilation During CPR
- Record updated
- 11 March 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Adult patients (18 years or older) with in-hospital cardiac arrest receiving manual ventilation via bag-mask or artificial airway
Who cannot take part
- Patients receiving Extracorporeal Membrane Oxygenation (ECMO)
- Inability to estimate predicted body weight (e.g., extreme body habitus or lack of height data)
- Known pregnancy
Where in United States
Also in 1 other country, 1 site
- Rush University Medical CenterChicago, United StatesContact: JIE LI, PhDNot yet recruiting
About the trial
What the trial wants to find out
Cardiac arrest is a life-threatening emergency that requires immediate treatment with cardiopulmonary resuscitation (CPR). While chest compressions circulate blood, manual ventilation provides oxygen to the patient. Current CPR guidelines recommend specific ventilation rates and tidal volumes, but studies show that clinicians often deliver too much or too little ventilation due to a lack of monitoring tools, potentially reducing the effectiveness of CPR and impacting survival.
Read full original descriptionShow less
The PRECISION-CPR study is a multi-center, randomized controlled trial designed to evaluate whether using real-time feedback devices to precisely control ventilation during CPR can improve patient outcomes. Adult patients experiencing in-hospital cardiac arrest will be randomized to receive either standard manual ventilation guided by clinician experience or precision-controlled ventilation tailored to the patient's predicted body weight using real-time monitoring devices.
The primary outcome of the study will be return of spontaneous circulation (ROSC). Secondary outcomes will include survival to hospital discharge, neurological recovery, and other clinical measures. By addressing the limitations of current ventilation practices, this study aims to generate evidence to guide future resuscitation guidelines and improve survival rates after cardiac arrest.
The 2 groups in the trial
- Precision-Controlled Ventilation with Real-Time FeedbackTreatment being tested
Patients will receive manual ventilation during CPR using real-time feedback devices (EOlife) to guide tidal volume (6-8 mL/kg predicted body weight) and ventilation rate (10 breaths per minute) delivery, ensuring adherence to guideline-recommended ventilation parameters.
- Standard of Care Ventilation During CPRExisting treatment, for comparison
Patients will receive manual ventilation during CPR per standard practice without real-time feedback, using clinician judgment for tidal volume (visible chest rise) and ventilation rate, consistent with American Heart Association guidelines.
Treatment: Standard Manual Ventilation During CPR
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- PRecision-Controlled Ventilation to Enhance Cardiac Arrest Intervention and Survival IN CPR: A Multi-Center Randomized Controlled Trial
- Record updated
- 11 March 2026